Oncoscience Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Oncoscience General Information
Description
Developer of biopharmaceutical drugs intended to focus on the treatment of orphan indications in oncology. The company offers therapeutic options that can be used for the treatment of several malignancies, thereby enabling its clients to be provided with products that serve as an adequate treatment of these orphan diseases.
Contact Information
Website
www.oncoscience.deCorporate Office
- Osterbrooksweg 59
- 22869 Schenefeld
- Germany
Corporate Office
- Osterbrooksweg 59
- 22869 Schenefeld
- Germany
Oncoscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Oncoscience Patents
Oncoscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2016299368-A1 | Treatment of patients diagnosed with pancreatic ductal adenocarcinoma using monoclonal antibodies against the epidermal growth factor receptor (egfr) | Active | 27-Jul-2015 | ||
| AU-2016299368-B2 | Treatment of patients diagnosed with pancreatic ductal adenocarcinoma using monoclonal antibodies against the epidermal growth factor receptor (egfr) | Active | 27-Jul-2015 | ||
| CA-2992375-A1 | Treatment of patients diagnosed with pancreatic ductal adenocarcinoma using monoclonal antibodies against the epidermal growth factor receptor (egfr) | Pending | 27-Jul-2015 | ||
| EP-3328426-A1 | Treatment of patients diagnosed with pancreatic ductal adenocarcinoma using monoclonal antibodies against the epidermal growth factor receptor (egfr) | Active | 27-Jul-2015 | ||
| EP-3328426-B8 | Treatment of patients diagnosed with pancreatic ductal adenocarcinoma using monoclonal antibodies against the epidermal growth factor receptor (egfr) | Active | 27-Jul-2015 | A61K39/395 |
Oncoscience Signals
Oncoscience FAQs
-
When was Oncoscience founded?
Oncoscience was founded in 2001.
-
Where is Oncoscience headquartered?
Oncoscience is headquartered in Schenefeld, Germany.
-
What is the size of Oncoscience?
Oncoscience has 4 total employees.
-
What industry is Oncoscience in?
Oncoscience’s primary industry is Biotechnology.
-
Is Oncoscience a private or public company?
Oncoscience is a Private company.
-
What is Oncoscience’s current revenue?
The current revenue for Oncoscience is .
-
When was Oncoscience acquired?
Oncoscience was acquired on 16-Jul-2015.
-
Who acquired Oncoscience?
Oncoscience was acquired by Innokeys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process